Release Date: June 1, 2010
Pharmacy Release Date:: December 2, 2010
Expiration Date: May 31, 2012

Media

Video/slides with interactive questions. Printable PDF also available.

Target Audience

This activity has been designed to meet the educational needs of OB/GYNs and primary care practitioners including internal medicine, nurse practitioners, family practice, and physician assistants.

Activity Description/Statement of Need

Hypoactive sexual dysfunction disorder (HSDD) occurs among women of all ages but continues to be underdiagnosed and undertreated. A lack of patient-physician communication is a major reason underlying the failure to identify HSDD. Patients are reluctant to discuss sexual difficulties with their physicians, and physicians are reluctant to inquire about such issues. By recognizing the nature of these barriers and implementing strategies to overcome them, OB/GYNs and primary care practitioners can play an important role in promoting more widespread screening for female sexual dysfunction (FSD), leading to greater use of diagnostic modalities designed to ascertain the exact nature of the dysfunction.¹⁴

Educational Objectives

Upon completion of this educational initiative, participants will be able to:

1. Confidently communicate with patients about female sexual dysfunction specifically HSDD.
2. Initiate dialogue with patients about sexual dysfunction and health.
3. Implement screening tools for the diagnosis of female sexual dysfunction; specifically HSDD.
4. Summarize the epidemiology of female sexual dysfunction; specifically HSDD.

Faculty Information and Disclosures

Sheryl A. Kingsberg, PhD (click here for full bio) Professor of Reproductive Biology Case Western Reserve University School of Medicine Chief, Division of Behavioral Medicine University Hospitals Case Medical Center Cleveland, Ohio Dr. Kingsberg has disclosed she serves as a consultant for Boehringer Ingelheim, Johnson & Johnson and Wyeth. She has received grant/research support from Boehringer-Ingelheim and BioSante Pharmaceuticals.

The planners and managers have no financial or other relationship to products or devices with commercial interests related to the content of this CE/CME activity.

Nancy Baxter has no financial relationships to disclose relating to the content of this activity. Jennifer Davis-Beck, MD has no financial relationships to disclose relating to the content of this activity.

CEC partners and staff have no real or apparent conflicts of interest.

Instructions

To receive a statement of credit, you must:

• Review the full content of the activity and reflect upon its teachings
• Complete the questions within the activity
• Complete the evaluation at the end of the activity.

Your statement of credit will be issued immediately upon successful completion of the evaluation form.

Accreditation

Medicine

Creative Educational Concepts, Inc. (CEC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. CEC designates this educational activity for a maximum of 1.50 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity. Statements of credit will be issued immediately online upon successful completion of the activity and evaluation.

AAFP

This activity has been reviewed and is acceptable for up to 1.50 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins June 1, 2010. Term of approval is for two years from this date with option for yearly renewal. When reporting CME credit, AAFP members should report total Prescribed and Elective credit earned for this activity. It is not necessary for members to label credit as evidence-based CME for reporting purposes.

Pharmacy

Creative Educational Concepts, Inc. (CEC) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based activity has been assigned ACPE # 0245-0000-10-143-H01-P and will award 1.5 contact hours (0.15 CEUs) of continuing pharmacy education credit. CEC complies with the Criteria for Quality for continuing education programming.

Fee

This activity is complimentary.

Disclosure Declaration

It is the policy of CEC to ensure independence, balance, objectivity, scientific rigor, and integrity in their continuing education activities.

Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.

Fair balance is achieved through ongoing and thorough review of all presentation materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by CEC for any product or manufacturer identified.

Unlabeled Use Disclosure

This activity may include discussions of products or devices that are not currently approved for use by the Food and Drug Administration (FDA), or are currently investigational.

Supporting Organization

This activity is supported by an educational grant from

Computer Hardware/Software Requirements

Windows®

• Intel Pentium ll 450MHz or faster processor (or equivalent)
• 128MB of RAM
• Microsoft Windows 98, Windows Me, Windows 2000, Windows XP, Windows Server 2003
• Microsoft Internet Explorer 5.5, Firefox l.x, Mozilla l.x, Netscape 7.x or later, AOL 9, Opera 7.11 or later

Macintosh

• PowerPC G3 SOOMI-Iz or faster processor
• 128MB of RAM 4 4
• Mac OS X v.l0.l.x, l0.2.x, l0.3.x, or l0.4.x
• Intemet Explorer 5.2, Firefox 1.x, Mozilla l.x, Netscape 7.x or later, AOL for Mac OS X, Opera 6, Safari l.x` or later